# Lila Sciences

## Company Overview
| Attribute | Details |
|-----------|---------|
| **Company Name** | Lila Sciences |
| **Founded** | 2023 (in Flagship labs) |
| **Headquarters** | Cambridge, MA, USA (Flagship Pioneering) |
| **Founded By** | Flagship Pioneering |
| **Leadership** | Geoffrey von Maltzahn, PhD (Flagship General Partner); George Church, PhD (Chief Scientist) |
| **Category** | Scientific AI / Autonomous Labs |
| **One-Sentence Description** | First scientific superintelligence platform with autonomous AI labs, $550M total funding, targeting full automation of the scientific method |

## Funding
| Attribute | Details |
|-----------|---------|
| **Total Funding** | $550M |
| **Seed Round** | $200M (March 2025) |
| **Series A** | $350M (October 2025) |
| **Valuation** | $1.3B (Series A) |

## Funding Details

### Seed Round (March 2025)
- Amount: $200M committed
- Lead: Flagship Pioneering
- Investors: General Catalyst, March Capital, Altitude Life Science Ventures, ARK Venture Fund, Blue Horizon Advisors, Modi Ventures, State of Michigan Retirement System, ADIA subsidiary

### Series A (October 2025)
- Amount: $350M
- First Close Co-Leads: Braidwell, Collective Global
- Additional Investors: NVentures (Nvidia), Analog Devices, IQT, Dauntless Ventures, Catalio Capital Management, Pennant Investors
- Valuation: $1.3B

## Leadership

### Geoffrey von Maltzahn, PhD
- Flagship Pioneering General Partner
- Company lead

### George Church, PhD
- Chief Scientist
- CRISPR pioneer
- Harvard professor
- World-renowned geneticist

## Mission: Scientific Superintelligence
Building the world's first:
- Scientific superintelligence platform
- Fully autonomous labs for:
  - Life sciences
  - Chemical sciences
  - Materials sciences

## Technology: AI Science Factories

### Concept
Automated labs with:
- Robotics
- Sensors
- Specialized AI models
- Continuous experimentation

### Process
1. AI generates hypotheses
2. Executes experiments
3. Measures results
4. Decides next steps
5. Humans guide big questions
6. Day-to-day discovery = machines

### Capabilities
- Fully automate the scientific method
- Process vast data
- Make predictions
- Design and conduct new experiments
- Generate and test hypotheses in real-world environments

## Performance Claims
- Platform tested across multiple disciplines
- Performs superior to current benchmarks
- Can assist scientists in designing experiments

## Competitive Position
Competing with:
- Recursion Pharmaceuticals
- Isomorphic Labs (Google)
- Insilico Medicine
- Genesis Therapeutics
- Chai Discovery

### Differentiation
- Full automation of scientific method
- Autonomous labs (not just software)
- Cross-domain (life, chemical, materials)
- Flagship Pioneering backing
- George Church credibility

## Parent: Flagship Pioneering
- Founded Moderna
- Leading life sciences VC/incubator
- Track record of unicorn creation

## Strategic Notes
- $550M for scientific AI = massive bet
- George Church as Chief Scientist = credibility
- Flagship Pioneering = proven biotech incubator
- Autonomous labs = hardware + software
- Cross-domain approach = broader applicability
- "Scientific superintelligence" = ambitious framing
- Nvidia backing = compute partnership
- $1.3B valuation in ~2 years

## Status
Active - Leading scientific AI platform

## Sources
- BioPharma Dive, Flagship Pioneering, Fierce Biotech, HPCwire, MobiHealthNews, PR Newswire
